Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1996-08-12
1998-12-22
Russel, Jeffrey E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
514 2, 514565, 604 21, 604 53, A61K 31195, A61K 3802, A61M 2510, A61N 130
Patent
active
058520589
ABSTRACT:
Vessels suffering vascular injury from angioplasty are treated with L-arginine intramurally. The incidents associated with restenosis are substantially reduced providing for a reduced incidence of restenosis as a result of the injury.
REFERENCES:
patent: 5171217 (1992-12-01), March et al.
patent: 5236413 (1993-08-01), Feiring
patent: 5286254 (1994-02-01), Shapland et al.
patent: 5318531 (1994-06-01), Leone
patent: 5428070 (1995-06-01), Cooke et al.
patent: 5482925 (1996-01-01), Hutsell
patent: 5499971 (1996-03-01), Shapland et al.
patent: 5569198 (1996-10-01), Racchini
patent: 5628730 (1997-05-01), Shapland et al.
patent: 5634895 (1997-06-01), Igo et al.
McNamara et al., L-Arginine Inhibits Balloon Catheter... Biochem, Biophys. Res. Comm. vol. 193, No. 1, pp. 291-296 May 28, 1993.
Cooke John P.
Lim Tai T.
Schwarzacher Sverin
Yeung Alan C.
Rowland Bertram I.
Russel Jeffrey E.
The Board of Trustees of the Leland Stanford Junior University
LandOfFree
Intramural delivery of nitric oxide enhancer for inhibiting lesi does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Intramural delivery of nitric oxide enhancer for inhibiting lesi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Intramural delivery of nitric oxide enhancer for inhibiting lesi will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2048127